Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

E-PROT-45

ABSTRACT: Region and cell-type resolved quantitative proteomic map of the human heart.

TISSUE(S): Mitral Valve, Right Atrium, Pulmonary Valve, Pulmonary Artery, Atrial Septum, Left Atrium, Right Ventricle, Pulmonary Vein, Tricuspid Valve, Ventricular Septum, Aorta, Inferior Vena Cava, Left Ventricle, Aortic Valve

PROVIDER: E-PROT-45 | ExpressionAtlas | 2022-01-07

REPOSITORIES: ExpressionAtlas

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	E-PROT-12-analysis-methods.tsv	Tabular
	E-PROT-45-analysis-methods.tsv	Tabular
	E-PROT-45-configuration.xml	Xml
	E-PROT-45-factors.xml	Xml
	E-PROT-45-zoomifications-log.tsv	Tabular

Items per page:

1 - 5 of 12

Similar Datasets

E-PROT-11

Project description:Initial quantitative proteomic map of 28 mouse tissues using the SILAC mouse

2021-11-09 | E-PROT-11 | ExpressionAtlas

RBM20 orchestrates cardiac pre-mRNA

Project description:The RNA-binding protein RBM20 has been implicated in dilated cardiomyopathy (DCM), a major cause of chronic heart failure. To determine how RBM20 regulates alternative splicing, we combined transcriptome-wide CLIP-seq, RNA-seq, and quantitative proteomics in cell culture, rat, and human hearts. Our analyses revealed a distinct RBM20 RNA-recognition element in predominantly intronic binding sites and linked repression of exon splicing with RBM20-binding near 3prime- and 5prime-splice sites. Our proteomic data show RBM20 interaction with U1- and U2-snRNPs and suggests splicing repression through spliceosome stalling at complex A. Among direct RBM20 targets are several genes involved in DCM as well as new genes not previously associated with the disease process. In human failing hearts, we demonstrate that reduced expression levels of RBM20 affect alternative splicing of several direct targets, indicating that differences in RBM20 gene expression may affect cardiac function. These findings reveal a new mechanism to understand the pathogenesis of human heart failure. The provided data files for RNA-seq contain information for reads that map to human RBM20 only.

2014-11-11 | E-MTAB-2572 | biostudies-arrayexpress

Single cell chromatin profiling of human cardiogenesis development and iPS derived cardiac cell types

Project description:In this study, we map chromatin accessibility at single-cell resolution in the developing human heart and compare it with iPS derived cardiac cell types.

2022-01-30 | GSE181346 | GEO

The transcriptomic and proteomic map of human primary cells

Project description:The transcriptomic and proteomic map of human primary cells

| PRJNA787705 | ENA

Region and cell-type resolved quantitative proteomic map of the human heart and its application to atrial fibrillation

Project description:The heart is a central human organ and its diseases are the leading cause of death worldwide, but an in-depth knowledge of the identity and quantity of its constituent proteins is still lacking. Here we determine the healthy human heart proteome by measuring 16 anatomical regions and three major cardiac cell types by high-resolution mass spectrometry-based proteomics. From low microgram sample amounts, we quantified over 11,000 proteins in this high dynamic range tissue. We combined copy numbers per cell with protein organellar assignments to build a model of the heart proteome at the subcellular level. Analysis of cardiac fibroblasts identified 25 cellular receptors as potential new cell surface markers. Application of our heart map to an atrial fibrillation study revealed signatures of distinct mitochondrial dysfunctions. The heart map is available at maxqb.biochem.mpg.de as a resource for future analyses of normal heart function and disease.

2019-10-03 | MSV000084410 | MassIVE

Region and cell-type resolved quantitative proteomic map of the human heart and its application to atrial fibrillation

2017-11-14 | PXD006675 | Pride

Large-Scale Discovery of Enhancers from Human Heart Tissue

Project description:Development and function of the human heart depend on the dynamic control of tissue-specific gene expression by distant-acting transcriptional enhancers. While large numbers of heart enhancers have been identified using the mouse as a model system, many of these regulatory sequences are poorly conserved in the human genome. To generate an accurate genome-wide map of human heart enhancers, we used an epigenomic enhancer discovery approach and identified ~6,200 candidate enhancer sequences directly from fetal and adult human heart tissue. Consistent with their predicted function, these elements were markedly enriched near genes implicated in heart development, function and disease. To further validate their in vivo enhancer activity, we tested 65 of these human sequences in a transgenic mouse enhancer assay and observed that 43 (66%) drove reproducible reporter gene expression in the heart. These results support the discovery of a genome-wide set of non-coding sequences highly enriched in human heart enhancers which is likely to facilitate down-stream studies of the role of enhancers in development and pathological conditions of the heart. Examination of AcCBP/p300 binding in human adult heart, human fetal (16wk) heart and mouse postnatal day 2 heart

2011-12-04 | E-GEOD-32587 | biostudies-arrayexpress

Comprehensive Mapping of Transcriptionally-active Enhancers During Murine Cardiogenesis at Single Cell Resolution

Project description:An in-depth understanding of the complex mechanisms that orchestrate normal embryonic heart development is required to disambiguate the origin of congenital heart disease. However, the epigenetic landscapes governing cell type-specific gene expression patterns during heart development at single cell resolution has yet to be revealed. Here we use simultaneous single cell RNA and assay for transposase accessible chromatin sequencing to construct a comprehensive multimodal map of embryonic murine heart development, profiling cell type- and timepoint-specific epigenetic regulatory elements as well as their gene targets. Furthermore, we compare these regulatory elements with published GWAS hits to map variants implicated in key developmental processes and clinical phenotypes to enhancers for genes that are actively transcribed during cardiac development. Taken together, our work provides a rich resource for the broader scientific community that empowers future studies in heart development and disease and offers a simple computational framework for integrating and profiling multiomic data in single cells.

2025-10-31 | GSE244783 | GEO

GlycoTCFM: glycoproteomics based on two complementary fragmentation methods reveals distinctive O-glycosylation in human semen

Project description:Human semen, consisting of spermatozoa and seminal plasma, represents a special clinical sample type in human body fluid. Protein glycosylation in semen plays key roles in spermatogenesis, maturation, capacitation, sperm–egg recognition, motility of sperm and fertilization. In this study, we profiled the most comprehensive O-glycoproteome map of human semen using our recently presented glycoproteomics based on two complementary fragmentation methods (GlycoTCFM). We showed that semen contains a lot of novel and distinctive O-glycoproteins, which are mostly located in extracellular region and membrane, enriched in the biological processes of cell adhesion and angiogenesis, and mainly involved in multiple biological functions including extracellular matrix structural constituent and binding.

2023-07-28 | PXD044163 |

A 3D molecular atlas of the chick embryonic heart

Project description:We performed a detailed analysis of gene expression in the 2-day (HH12) embryonic chick heart. RNA-seq of 13 microdissected heart regions reveals regionalised expression of about 15,000 genes (Dataset 1). Of these, 131 genes that are differentially expressed (FPKM ≥20, fold change ≥1.1-4.0) within a region compared to the other 12 regions were studied by in situ hybridisation (bold text in Dataset 1) and used to generate a 3D molecular map of the heart at this stage of development.

2019-10-02 | E-MTAB-7663 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data